Comparison of the new drug research and development platforms at home and abroad: A preliminary study / 国际药学研究杂志

ABSTRACT

The new drug research and development(R&D) platforms are comprehensive, open and continuously developing organic systems which integrate such elements as technologies and standards related to the R&D of innovative drugs and serve as pilars and integration media. These platforms are macroscopic and integrated at the governmental level, large and systematic in big pharmaceutical enterprises and research institutes, and detailed and professional in medium and small enterprises. The construction of new drug R&D platforms in China experienced germination and rudiment stages during "9th Five-year" period, and has now entered the full-fledged developing stage with the support of Scientific and Technological Major Special Project - "Key New Drugs Creation and Manufacturing", and has evolved from single technological R&D centers to integrated technology platforms with complete pipelines. By comparing the development of domestic and international new drug R&D platforms, this paper puts forward some suggesions on how to develop and manage the Chinese platform and examines its future prospects.